Literature DB >> 11286015

Matrix metalloproteinases and bladder cancer.

H Kanayama1.   

Abstract

Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes which degrade the extracellular matrix or components of the basement membrane. They have essential roles in tumor invasion and metastasis. In bladder cancer, elevated MMP-2 and MMP-9 expression in tumor tissues, correlated with tumor stage, grade or prognosis, were reported in several studies. Moreover, high levels of serum or urine MMP and TIMP were observed in patients with bladder cancer especially in advanced cases. However, the true roles of MMPs and TIMPs in bladder cancer progression are not yet clarified. Here, we discuss the roles and clinical implications of MMPs in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286015

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  16 in total

1.  Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.

Authors:  Xinsheng Wang; Kejun Zhang; Lijiang Sun; Jianqiang Liu; Haipin Lu
Journal:  Med Oncol       Date:  2010-10-30       Impact factor: 3.064

Review 2.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

3.  Soluble Expression of Bladder Cancer Biomarker Matrix Metalloproteinase 1.

Authors:  Xuefei Jin; Dan Zhang; Hongyan Li; Ning Jin; Tingting Liu; Xiangbo Kong
Journal:  J Clin Lab Anal       Date:  2014-07-10       Impact factor: 2.352

4.  Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.

Authors:  Wa'el Al Rawashdeh; Susanne Arns; Felix Gremse; Josef Ehling; Ruth Knüchel-Clarke; Stefan Kray; Felix Spöler; Fabian Kiessling; Wiltrud Lederle
Journal:  Neoplasia       Date:  2014-03       Impact factor: 5.715

5.  Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line.

Authors:  Yunhua Tang; Xiangyang Zhang; Fan Qi; Mingfeng Chen; Yuan Li; Longfei Liu; Wei He; Zhuo Li; Xiongbing Zu
Journal:  Exp Ther Med       Date:  2015-02-25       Impact factor: 2.447

6.  Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer.

Authors:  Yongning Zhou; Gaozhong Li; Jing Wu; Zhiyi Zhang; Zhengqi Wu; Ping Fan; Tianjun Hao; Xu Zhang; Min Li; Fuhua Zhang; Qiang Li; Bing Lu; Liang Qiao
Journal:  Tumour Biol       Date:  2010-06-19

7.  Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.

Authors:  Amr Ahmed El Badry; Amal Abou El-Fadle; Abdel Latif El-Balshy
Journal:  MedGenMed       Date:  2007-07-03

Review 8.  The bladder extracellular matrix. Part I: architecture, development and disease.

Authors:  Karen J Aitken; Darius J Bägli
Journal:  Nat Rev Urol       Date:  2009-11       Impact factor: 14.432

9.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

10.  Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.

Authors:  Hanief M Shahjee; Kristopher R Koch; Li Guo; Chen-Ou Zhang; Susan K Keay
Journal:  J Exp Clin Cancer Res       Date:  2010-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.